Risk of sudden death after successful accessory atrioventricular pathway ablation in resuscitated patients with Wolff-Parkinson-White syndrome

Journal of Cardiovascular Electrophysiology

Volumn 13, Issue 3, 2002, Pages 231-236

  Antz, Matthias ^a   Weiß, Christian ^b   Volkmer, Marius ^a   Hebe, Joachim ^a   Ernst, Sabine ^a   Ouyang, Feifan ^a   Kuck, Karl Heinz ^a  

^a DEPARTMENT OF CARDIOLOGY   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Ablation; Follow up studies; Resuscitation; Wolff Parkinson White syndrome

Indexed keywords

ANTIARRHYTHMIC AGENT;

ACUTE HEART INFARCTION; ADOLESCENT; ADULT; AGED; ARTICLE; ATRIOVENTRICULAR CONDUCTION; CATHETER ABLATION; CHILD; CLINICAL ARTICLE; DEFIBRILLATOR; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART ARREST; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE FIBRILLATION; HUMAN; MALE; PRIORITY JOURNAL; RECURRENCE RISK; RESUSCITATION; SUDDEN DEATH; SYNCOPE; WOLFF PARKINSON WHITE SYNDROME;

EID: 0036196752     PISSN: 10453873     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1540-8167.2002.00231.x     Document Type: Article

References (30)

1. Ventricular fibrillation. A possible mechanism of sudden death in patients with Wolff-Parkinson-White syndrome
2. Onset of atrial fibrillation during antidromic tachycardia: Association with sudden cardiac arrest and ventricular fibrillation in a patient with Wolff-Parkinson-White syndrome
3. Ventricular fibrillation in the Wolff-Parkinson-White syndrome
4. Ventricular preexcitation in children and young adults. Atrial myocarditis as a possible trigger of sudden death
5. A population study of the natural history of Wolff-Parkinson-White syndrome in Olmsted county, Minnesota, 1953-1989
6. The Wolff-Parkinson-White electrogram. A follow-up study of five to twenty-eight years
7. Prevalence and natural history of Wolff-Parkinson-White syndrome in a population of 103,048 people
8. Cost-effectiveness of radiofrequency ablation compared with other strategies in Wolff-Parkinson-White syndrome
9. Sensitivity and specificity of invasive and noninvasive testing for risk of sudden death in Wolff-Parkinson-White syndrome
10. Impact of clinical history and electrophysiologic characterization of accessory pathways on management strategies to reduce sudden death among children with Wolff-Parkinson-White syndrome
11. Multiple accessory pathways in the Wolff-Parkinson-White syndrome as a risk factor for ventricular fibrillation
12. Ventricular fibrillation in the Wolff-Parkinson-White syndrome
13. Idiopathic ventricular fibrillation
14. Out-of-hospital cardiac arrest. Use of electrophysiologic testing in the prediction of long-term outcome
15. Prognostic significance of arrhythmia inducibility or noninducibility at initial electrophysiologic study in survivors of cardiac arrest
16. Late outcome of survivors of out-of-hospital cardiac arrest with left ventricular ejection fractions ≥50% and without significant coronary arterial narrowing
17. Survivors of out-of-hospital cardiac arrest with apparently normal heart. Need for definition and standardized clinical evaluation
18. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: The Cardiac Arrest Study Hamburg (CASH)
19. Causes of death in the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial
20. Radiofrequency current catheter ablation of accessory atrioventricular pathways
21. Single-catheter approach to radiofrequency current ablation of left sided accessory pathways in patients with Wolff-Parkinson-White syndrome
22. Living anatomy of the atrioventricular junctions. A guide to electrophysiologic mapping. A consensus statement from the Cardiac Nomenclature Study Group
23. Patients with supraventricular tachycardia presenting with aborted sudden death: Incidence, mechanism and long-term follow-up
24. Precipitation of cardiac arrest by verapamil in patients with Wolff-Parkinson-White syndrome
25. Ventricular fibrillation following verapamil in the Wolff-Parkinson-White syndrome
26. Asymptomatic Wolff-Parkinson-White. Should we intervene?
27. Risk of sudden arrhythmic death in the Wolff-Parkinson-White syndrome: Current perspectives
28. Therapy of Wolff-Parkinson-White syndrome and concealed bypass tracts: Part I
29. Aborted sudden death in the Wolff-Parkinson-White syndrome
30. Sudden death in a young competitive athlete with Wolff-Parkinson-White syndrome